Comparison of renal and bone toxicities, and CV serum risk markers, in the assert study. 48 week results from a prospective randomised trial by Hans-Jürgen Stellbrink given during the 12th European AIDS Conference / EACS powered by - MULTIWEBCAST

12th European AIDS Conference / EACS

WELCOME MESSAGE

LIST OF PRESENTATIONS/COURSES

OTHER WEBCASTS

Webcasted Presentation

BROWSE:

ALL PRESENTATIONS/COURSES

SPEAKERS

PPT SLIDES

VIDEO PODCASTS

Comparison of renal and bone toxicities, and CV serum risk markers, in the assert study. 48 week results from a prospective randomised trial

Hans-Jürgen Stellbrink

Germany

PRESENTATION

16 slide(s) – 00:09:51 – English – 2009-11-13

Extra Features Available

VIDEO PODCAST

Rate & Comment

A A A


Rate:
Please let us know how useful this content was for you and feel free to write your comments below.

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™